Current role
Biotechnology · Healthcare
Board Member
2025-12-01–present
Ted Love
Board Member
Jazz Pharmaceuticals plc (JAZZ)Equibles does not estimate personal net worth.
Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get JAZZ alertsAbout Ted Love
Ted Love is recorded as Board Member at Jazz Pharmaceuticals plc (JAZZ) since December 1, 2025. Jazz Pharmaceuticals plc reported in an 8-K filed October 28, 2025 that Ted Love was appointed Class I director, effective December 1, 2025. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jazz Pharmaceuticals plc includes Bruce Cozadd (CEO and Board Member), Renee D. Gala (CEO), Renee Gala (CEO, COO and Board Member) and 7 others.
“On October 23, 2025, the board of directors (the "Board") of Jazz Pharmaceuticals plc (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Ted Love to the Board, effective as of December 1, 2025, as a Class I director for a term expiring at the annual general meeting of shareholders to be held in 2027.”
Affiliation history
-
Current
2025-12-01–present
Company network
Leadership on record at Jazz Pharmaceuticals plc
- Bruce Cozadd CEO, Board Member
- Renee D. Gala CEO
- Renee Gala CEO, COO, Board Member
- Matthew P. Young CFO
- Philip Johnson CFO
- Renée D. Galá CFO
- Chris Tovey COO
- Renée Galá COO
- Neena M. Patil General Counsel
- Patricia Carr Chief Accounting Officer